Neoadjuvant dose-dense gemcitabine and cisplatin (DDGC) in patients (pts) with muscle-invasive bladder cancer (MIBC): Final results of a multicenter phase II study.
Elizabeth R. Plimack
No relevant relationships to disclose
Jean H. Hoffman-Censits
No relevant relationships to disclose
Alexander Kutikov
No relevant relationships to disclose
Richard E. Greenberg
No relevant relationships to disclose
Marijo Bilusic
No relevant relationships to disclose
David Y. T. Chen
No relevant relationships to disclose
Rosalia Viterbo
No relevant relationships to disclose
Costas D. Lallas
No relevant relationships to disclose
Jianqing Lin
No relevant relationships to disclose
Edouard John Trabulsi
No relevant relationships to disclose
Daniel M. Geynisman
No relevant relationships to disclose
William Kevin Kelly
No relevant relationships to disclose
Marc C. Smaldone
No relevant relationships to disclose
Karthik Devarajan
No relevant relationships to disclose
Beth Adaire-Halenda
No relevant relationships to disclose
Charlotte Cione
No relevant relationships to disclose
Deborah Kilpatrick
No relevant relationships to disclose
Gail Duncan
No relevant relationships to disclose
Yu-Ning Wong
No relevant relationships to disclose